Loading...
Morgan Stanley reiterates its overweight rating on Rocket Lab, maintaining its target price of $105 and raising its bull market target price from $185 to $293. Morgan Stanley analysts believe that the acquisition of Iridium will broaden Rocket Lab's potential market space and reposition the company as a vertically integrated space platform. Although SapceX has scale and cost advantages over Rocket Lab, Rocket Lab is moving closer to the SapceX model.